Search

Purpose Present 1‐year data of the combined ophthalmology and rheumatology pediatric uveitis clinic at Leeds Teaching Hospitals. Methods Retrospective data collection Results An estimated 230 patients with JIA were screened by ophthalmology in this time period.21 different paediatric patients with iritis were managed from June 2011 to May 2012 in the joint clinic.8(38%) patients were male and 13(62%) female with age at diagnosis ranged from 0.5 – 12 years. 11 patients (52%) were diagnosed with oligoarticular and 5(23%) with polyarticular JIA,3 patients were ANA +, 3(14%) did not have any joint involvement.9 patients(43%) presented with vision of 0.2logMar or worse, and 4 continued to have vision worse than 0.2 logMar while 17 patients (81%) improved or maintained stable vision of 0.1 or better.3 patients had intermediate uveitis,1 had panuveitis and 1 had papillitis with iritis.2 had eye complications of lens opacities and 1 patient had retinal detachment.17(81%) patients received systemic treatment, with 12 receiving methotrexate +/‐ mycophenolate mofetil and 5(29%) receiving anti‐TNF α therapy (infliximab or adalimumab) in addition to methotrexate +/‐ mycophenolate mofetil. 13/16 patients with JIA (81%) had iritis associated with their joint flare‐ups. 9 patients (50%) out of 18 with joint pathology received intra‐articular steroid injections during this period and 6 received (28%) periocular steroid injection. A survey of the joint clinic by the patient and medical staff showed significantly high satisfaction rate. Conclusion The joint clinic has numerous benefits and is the right approach to manage a condition where communication is crucial between team monitoring (ophthalmology) and managing (rheumatology) the condition [ABSTRACT FROM AUTHOR]